The National Health Service (Pharmaceutical Services) and (Misuse of Drugs) (Electronic Communications) Order 2001

Amendment of the National Health Service (Pharmaceutical Services) Regulations 1992

2.—(1) The National Health Service (Pharmaceutical Services) Regulations 1992(1) are amended as follows.

(2) In regulation 2(1) (interpretation)—

(a) in the appropriate alphabetical position, insert—

““the 2000 Act” means the Electronic Communications Act 2000;”,

• ““electronic communication” has the same meaning as in section 15 of the 2000 Act;”,

• ““electronic signature” has the same meaning as in section 7 of the 2000 Act;”;

(b) in the definition of “prescription form”(2), after “means” insert “, subject to regulation 2A,”.

(3) After regulation 2, insert—

“2A.— (1) In these Regulations, where the conditions set out in paragraph (2) are met—

(a) the term “prescription form” includes data that—

(i) are created in an electronic form and signed with an electronic signature and are transmitted as an electronic communication;

(ii) are created in an electronic form and signed with an electronic signature, where both the data and the signature are entered on the prescription form in a non-legible manner;

(iii) are created in writing and signed with an electronic signature which is entered on the prescription form in a non-legible manner; or

(iv) are created in an electronic form and entered on the prescription form in a non-legible manner, and signed in ink;

(b) any reference to presentation of a prescription form includes transmission of data created in an electronic form as an electronic communication.

(2) The conditions are—

(a) that the prescription is an order for a drug or appliance and is issued by a doctor in connection with the provision of general medical services or personal medical services;

(b) that the order is not for an oxygen concentrator; and

(c) that the Secretary of State is satisfied that—

(i) the use of electronic means in order to create, sign and transmit prescriptions (or whichever of those purposes is applicable) is appropriate for the purposes of a pilot scheme on the use of electronic prescribing in relation to the doctor and, where relevant, the chemist and the premises at which the prescription is dispensed; and

(ii) the particular electronic means used by the doctor and, where relevant, the chemist concerned are suitable for the purposes of such a pilot scheme.”.

(1)

S.I. 1992/662. Relevant amending instruments are S.I. 1998/681, 1999/696 and 2000/593.

(2)

The definition of a “prescription form” was substituted by S.I. 1999/696 and amended by S.I. 2000/593.